ONTOLOGY REPORT - ANNOTATIONS
Term: 2,2'-iminobis[1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)ethanol]
Accession: CHEBI:64019
browse the term
Definition: A member of the class of chromanes that is 2,2'-iminodiethanol in which one hydrogen attached to each hydroxy-bearing carbon is replaced by a 6-fluorochroman-2-yl group.
Synonyms: related_synonym: 1,1'-bis(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-yl)-2,2'-iminodiethanol; C22H25F2NO4; InChI=1S/C22H25F2NO4/c23-15-3-7-19-13(9-15)1-5-21(28-19)17(26)11-25-12-18(27)22-6-2-14-10-16(24)4-8-20(14)29-22/h3-4,7-10,17-18,21-22,25-27H,1-2,5-6,11-12H2; InChIKey=KOHIRBRYDXPAMZ-UHFFFAOYSA-N; OC(CNCC(O)C1CCc2cc(F)ccc2O1)C1CCc2cc(F)ccc2O1; alpha,alpha'-(iminobismethylene)bis-(6-fluoro-3,4-dihydro-2H-1-benzopyran-2-methanol); alpha,alpha'-(iminodimethylene)bis-(6-fluoro-2-chromanmethanol)
xref_casrn: 99200-09-6
xref: ChEMBL:127569 "ChEMBL COMPOUND"; ChemIDplus:99200-09-6 "CAS Registry Number"
xref_mesh: MESH:C052753
xref: Reaxys:8729344 "Reaxys Registry Number"
2,2'-iminobis[1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)ethanol]
G
Adrb1
adrenoceptor beta 1
multiple interactions
ISO
1
263,025,655
263,027,055
RGD:6480464
CTD
G
Adrb1
adrenoceptor beta 1
affects binding
EXP
1
263,025,655
263,027,055
RGD:6480464
CTD
G
Adrb1
adrenoceptor beta 1
multiple interactions
EXP
1
263,025,655
263,027,055
RGD:6480464
CTD
G
Agt
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
multiple interactions
EXP
19
54,738,556
54,750,349
RGD:6480464
CTD
G
Ar
androgen receptor
increases expression
EXP
X
85,949,507
86,119,199
RGD:6480464
CTD
G
Ccl2
chemokine (C-C motif) ligand 2
decreases expression
ISO
10
70,256,263
70,258,061
RGD:6480464
CTD
G
Ccl2
chemokine (C-C motif) ligand 2
decreases secretion
ISO
10
70,256,263
70,258,061
RGD:6480464
CTD
G
Ccl2
chemokine (C-C motif) ligand 2
decreases secretion
ISO
10
70,256,263
70,258,061
RGD:6480464
CTD
G
Cyba
cytochrome b-245, alpha polypeptide
multiple interactions
EXP
19
52,713,150
52,721,609
RGD:6480464
CTD
G
Cybb
cytochrome b-245, beta polypeptide
multiple interactions
EXP
X
25,514,572
25,547,181
RGD:6480464
CTD
G
Ddah2
dimethylarginine dimethylaminohydrolase 2
multiple interactions
ISO
20
3,829,767
3,836,141
RGD:6480464
CTD
G
Ddah2
dimethylarginine dimethylaminohydrolase 2
increases activity
ISO
20
3,829,767
3,836,141
RGD:6480464
CTD
G
Ddah2
dimethylarginine dimethylaminohydrolase 2
increases expression
ISO
20
3,829,767
3,836,141
RGD:6480464
CTD
G
Dhcr24
24-dehydrocholesterol reductase
increases expression
ISO
5
127,637,438
127,662,621
RGD:6480464
CTD
G
Edn1
endothelin 1
decreases expression
ISO
17
28,303,886
28,309,775
RGD:6480464
CTD
G
Edn1
endothelin 1
decreases secretion
ISO
17
28,303,886
28,309,775
RGD:6480464
CTD
G
Esr2
estrogen receptor 2 (ER beta)
affects activity
ISO
6
98,691,167
98,775,299
RGD:6480464
CTD
G
Icam1
intercellular adhesion molecule 1
decreases expression
ISO
8
20,040,177
20,051,939
RGD:6480464
CTD
G
Il1a
interleukin 1 alpha
decreases expression
ISO
3
116,913,612
116,924,114
RGD:6480464
CTD
G
Ncf2
neutrophil cytosolic factor 2
multiple interactions
EXP
13
67,806,516
67,834,105
RGD:6480464
CTD
G
Nos3
nitric oxide synthase 3, endothelial cell
increases activity
ISO
4
6,158,847
6,179,441
RGD:6480464
CTD
G
Nos3
nitric oxide synthase 3, endothelial cell
increases expression
EXP
4
6,158,847
6,179,441
RGD:6480464
CTD
G
Nos3
nitric oxide synthase 3, endothelial cell
multiple interactions
EXP
4
6,158,847
6,179,441
RGD:6480464
CTD
G
Nox1
NADPH oxidase 1
multiple interactions
EXP
RGD:6480464
CTD
G
Nppb
natriuretic peptide B
increases expression
ISO
5
165,062,348
165,063,650
RGD:6480464
CTD
G
Pdgfa
platelet-derived growth factor alpha polypeptide
decreases expression
ISO
12
16,151,045
16,172,412
RGD:6480464
CTD
G
Pdgfb
platelet-derived growth factor beta polypeptide
decreases expression
ISO
7
118,244,385
118,262,021
RGD:6480464
CTD
G
Ptgs2
prostaglandin-endoperoxide synthase 2
decreases expression
ISO
13
64,427,288
64,432,978
RGD:6480464
CTD
G
Rac1
ras-related C3 botulinum toxin substrate 1
multiple interactions
EXP
12
11,380,314
11,400,531
RGD:6480464
CTD
G
Ren
renin
multiple interactions
EXP
13
46,262,936
46,275,213
RGD:6480464
CTD
G
Sele
selectin E
decreases expression
ISO
13
79,813,455
79,822,845
RGD:6480464
CTD
G
Selp
selectin P
decreases expression
ISO
13
79,886,614
79,922,180
RGD:6480464
CTD
G
Sod2
superoxide dismutase 2, mitochondrial
multiple interactions
EXP
1
41,862,997
41,870,327
RGD:6480464
CTD
G
Tnnt2
troponin T type 2 (cardiac)
multiple interactions
EXP
13
48,872,972
48,885,815
RGD:6480464
CTD
G
Vasp
vasodilator-stimulated phosphoprotein
multiple interactions
EXP
1
78,621,494
78,636,762
RGD:6480464
CTD
G
Vcam1
vascular cell adhesion molecule 1
decreases expression
ISO
2
212,277,654
212,297,376
RGD:6480464
CTD
G
Vipr1
vasoactive intestinal peptide receptor 1
increases expression
ISO
RGD:6480464
CTD
Term paths to the root one longest all shortest one shortest all one shortest and longest all longest
Path 1
CHEBI ontology
492574
chemical entity
492574
atom
491537
nonmetal atom
450591
halogen
101486
fluorine atom
10819
fluorine molecular entity
10819
organofluorine compound
10653
2,2'-iminobis[1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)ethanol]
37
(1R,1'R)-2,2'-iminobis\{1-[(2R,2'S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]ethanol\} +
0
(1S,1'S)-2,2'-iminobis\{1-[(2R,2'S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]ethanol\} +
0
Path 2
CHEBI ontology
492574
subatomic particle
491537
composite particle
491537
hadron
491537
baryon
491537
nucleon
491537
atomic nucleus
491537
atom
491537
main group element atom
461203
p-block element atom
458699
carbon group element atom
410677
carbon atom
407233
organic molecular entity
407226
organic molecule
359465
organic cyclic compound
298342
organic heterocyclic compound
154273
oxacycle
53252
benzopyran
18501
1-benzopyran
17612
chromanes
2267
2,2'-iminobis[1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)ethanol]
37
(1R,1'R)-2,2'-iminobis\{1-[(2R,2'S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]ethanol\} +
0
(1S,1'S)-2,2'-iminobis\{1-[(2R,2'S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]ethanol\} +
0